Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

8.7%

2 terminated/withdrawn out of 23 trials

Success Rate

86.7%

+0.2% vs industry average

Late-Stage Pipeline

9%

2 trials in Phase 3/4

Results Transparency

38%

5 of 13 completed trials have results

Key Signals

5 recruiting5 with results

Enrollment Performance

Analytics

Phase 2
12(60.0%)
Phase 1
5(25.0%)
N/A
1(5.0%)
Phase 4
1(5.0%)
Phase 3
1(5.0%)
20Total
Phase 2(12)
Phase 1(5)
N/A(1)
Phase 4(1)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (23)

Showing 20 of 23 trials
NCT04804241Phase 2Recruiting

Senicapoc in Alzheimer's Disease

Role: collaborator

NCT04516057Phase 3Recruiting

Nabilone for Agitation Blinded Intervention Trial

Role: collaborator

NCT05950906Phase 1Completed

Study to Assess PDM608 in Healthy Adult Subjects

Role: collaborator

NCT03634007Phase 1Completed

Gene Therapy for APOE4 Homozygote of Alzheimer's Disease

Role: collaborator

NCT02085265Phase 2Terminated

Telmisartan vs. Perindopril in Mild-Moderate Alzheimer's Disease Patients

Role: collaborator

NCT01606488Phase 4Active Not Recruiting

Effects of Brain Beta-Amyloid on Postoperative Cognition

Role: collaborator

NCT03752294Phase 1Withdrawn

A Novel Therapeutic Target for Alzheimer's Disease in Men and Women 50-85 Years of Age.

Role: collaborator

NCT05742698Phase 2Recruiting

Nabilone for Agitation in Frontotemporal Dementia

Role: collaborator

NCT03533257Phase 2Completed

Study to Assess the Safety and Biological Activity of AMX0035 for the Treatment of Alzheimer's Disease

Role: collaborator

NCT02862210Phase 2Completed

Low-Dose Lithium for the Treatment of Behavioral Symptoms in Frontotemporal Dementia

Role: collaborator

NCT04937452Phase 2Completed

Dopaminergic Therapy for Frontotemporal Dementia Patients

Role: collaborator

NCT04425148Not ApplicableRecruiting

Gamma-Induction in FrontoTemporal Dementia Trial

Role: collaborator

NCT04381468Phase 1Completed

SEMA4D Blockade Safety and Brain Metabolic Activity in Alzheimer's Disease (AD)

Role: collaborator

NCT03613844Phase 2Completed

DHA Brain Delivery Trial

Role: collaborator

NCT05109169Phase 2Recruiting

METformin and FINGER Intervention to Prevent Cognitive Impairment and Disability in Older Adults at Risk for Dementia

Role: collaborator

NCT02450253Phase 2Completed

Perfusion by Arterial Spin Labelling Following Single Dose Tadalafil in Small Vessel Disease (PASTIS) Trial

Role: collaborator

NCT05570370Unknown

Eardream Data Collection in Colombia Supported by ADDF

Role: collaborator

NCT05320471Unknown

Eardream Data Collection in Switzerland Supported by ADDF

Role: collaborator

NCT02292238Phase 2Completed

Benfotiamine in Alzheimer's Disease: A Pilot Study

Role: collaborator

NCT01388478Phase 2Completed

Safety Study of R(+)Pramipexole to Treat Early Alzheimer's Disease

Role: collaborator